Onyx Bridge Wealth Group’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Onyx Bridge Wealth Group’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,841	Closed	-$6.82K	–	299
2024 Q2	$6.82K	Hold	2,841	–	–	﹤0.01%	272
2024 Q1	$9.44K	Hold	2,841	–	–	﹤0.01%	262
2023 Q4	$11.9K	Buy	+2,841	New	+$21.4K	﹤0.01%	250

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Onyx Bridge Wealth Group's ASLN Position: Q3 2024 in Review

Onyx Bridge Wealth Group sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 2,841 shares — an estimated $6.82K sold.

Onyx Bridge Wealth Group first reported a position in ASLN in Q4 2023 and held it in 3 quarters. The position peaked at $11.9K in Q4 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Onyx Bridge Wealth Group reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Onyx Bridge Wealth Group sold 2,841 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $6.82K.
Onyx Bridge Wealth Group first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2023 and held it in 3 quarters.
Onyx Bridge Wealth Group's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $11.9K in Q4 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Onyx Bridge Wealth Group's 13F filing for Q3 2024, filed 17 Oct 2024.